Falchi, L., Baron, J. M., Orlikowski, C. A., & Ferrajoli, A. (2016). BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. Mediterranean Journal of Hematology and Infectious Diseases, 8, e2016011. https://doi.org/10.4084/mjhid.2016.011